Emtriva
NDC Package 53808-0801-1
Package Information
Emtriva is ® is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.Additional important information regarding the use of EMTRIVA for the treatment of HIV-1 Infection:EMTRIVA should not be coadministered with ATRIPLA®, TRUVADA®, or lamivudine-containing products [See Warnings and Precautions (5.3)].In treatment-experienced patients, the use of EMTRIVA should be guided by laboratory testing and treatment history [See Clinical Pharmacology (12.4)]. Marketed by State Of Florida Doh Central Pharmacy, this product is identified by NDC 53808-0801 and is authorized under FDA application NDA021500.
Identification & Billing
- RxCUI: 403875 - emtricitabine 200 MG Oral Capsule
- RxCUI: 404587 - Emtriva 200 MG Oral Capsule
- RxCUI: 404587 - emtricitabine 200 MG Oral Capsule [Emtriva]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 53808 - State Of Florida Doh Central Pharmacy
- 53808-0801 - Emtriva
- 53808-0801-1 - 30 CAPSULE in 1 BLISTER PACK
- 53808-0801 - Emtriva
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 53808-0801-1 identifies a specific commercial package of 30 capsule in 1 blister pack of Emtriva, labeled by State Of Florida Doh Central Pharmacy. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by State Of Florida Doh Central Pharmacy on July 01, 2009. The current certification is valid through December 31, 2018.
How is this State Of Florida Doh Central Pharmacy product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 53808080101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.